CureSearch to fund new study for aggressive paediatric bone cancer 

Bone cancer

CureSearch for Children’s Cancer, a national non-profit working to end childhood cancer by driving targeted and innovative research in an accelerated time frame, will fund a novel project aimed at developing therapies for osteosarcoma, an aggressive form of bone cancer.  

Kristen VanHeyst, DO of University Hospitals Rainbow Babies & Children’s Hospital’s Angie Fowler Adolescent & Young Adult Cancer Institute, received a CureSearch Young Investigator Award to find immunotherapeutic options for osteosarcoma.   

Although overall survival rates for osteosarcoma are improving, there have been no significant improvements in survival outcomes for patients with metastatic pulmonary osteosarcoma – osteosarcoma that has spread. This project may highly impact the survival of osteosarcoma patients by offering real clinical opportunities for treatment.  

Dr VanHeyst will target the molecule TGF-ß, which is produced by osteosarcoma cells and immune cells in the tumour microenvironment. The presence of TGF-ß dampens the ability of the patient’s immune system to eradicate this tumour.  

“This project is innovative and may highly impact the survival of paediatric and adolescent and young adult patients with osteosarcoma by offering hope for finding curative options,” said Holly Zink, Director of Research and Programs. 

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free